Login / Signup

Rationale and Design of the H-REPLACE Study: Safety and Efficacy of LMWH Versus Rivaroxaban in ChinEse Patients HospitaLized with Acute Coronary SyndromE.

Yichao XiaoLiang TangQiming LiuXinqun HuZhenfei FangSheng-Hua Zhou
Published in: Cardiovascular drugs and therapy (2020)
ClinicalTrials.gov; NCT03363035.
Keyphrases
  • acute coronary syndrome
  • atrial fibrillation
  • percutaneous coronary intervention
  • pulmonary embolism
  • antiplatelet therapy